SWOG clinical trial number
SWOG-7430

5-Fluorouracil and Adriamycin in the Treatment of Incurable Hepatoma

Closed
Abbreviated Title
5-Fluorouracil and Adriamycin in the Treatment of Incurable Hepatoma
Activated
11/05/1974
Closed
06/11/1976

Research committees

Gastrointestinal Cancer

Publication Information Expand/Collapse

1977

Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.

LH Baker;JH Saiki;SE Jones;JS Hewlett;RW Brownlee;RL Stephens;VK Vaitkevicius Cancer Treat Rep 61:1595-97

1976

5-fluorouracil and adriamycin therapy for hepatoma.

LH Baker;VK Vaitkevicius AACR 17:215 #859

Other Clinical Trials

SWOG Clinical Trial Number
CTSU/A022101

A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
Research Committee(s)
Gastrointestinal Cancer
Activated
01/10/2023
Open
SWOG Clinical Trial Number
S2107

Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
06/06/2022
Accrual
71%
Open
Phase
SWOG Clinical Trial Number
S2104

A Phase II Randomized Trial of Postoperative Adjuvant Capecitabine and Temozolimide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
Research Committee(s)
Gastrointestinal Cancer
Activated
10/14/2021
Accrual
27%
Open
Phase